论文部分内容阅读
1 资料与方法 1.1 临床资料 51例患者为1995午5月～1998年6月间的住院病人,其中肝炎后肝硬变36例,血吸虫病肝纤维化5例,亚急性重型肝炎2例,慢性重型肝炎5例,原发性肝癌2例,肝炎后肝硬变合并血吸虫病肝纤维化1例。51例患者被随机分成2组.善得定治疗组35例,垂体后叶素治疗组16例,其中男性38例,女性13例,平均年龄52岁(30～79岁)。所有病例均有呕血与黑便病史,出血量都在500ml以上。 1.2 治疗方法 善得定组首剂以善得定100—200pg加入0.9％生理盐水20ml中缓慢静推,继以251μg/h速度静脉维持。垂体后叶素组以垂体后叶素按0.2u/min的速度静脉滴注。2组病例均在出血停止(无呕血、血压及脉搏正常平稳、大便转
1 Materials and Methods 1.1 Clinical data 51 patients were hospitalized from May 1995 to June 1998 in which 36 cases of posthepatitis cirrhosis, 5 cases of schistosomiasis hepatic fibrosis, 2 cases of subacute severe hepatitis, chronic 5 cases of severe hepatitis, 2 cases of primary liver cancer, liver cirrhosis combined with schistosomiasis hepatic fibrosis in 1 case. Fifty-one patients were randomly divided into two groups: 35 cases in the treatment group and 16 cases in the pituitrin treatment group, including 38 males and 13 females, with an average age of 52 years (30-79 years). All cases have vomiting and melena history, bleeding in more than 500ml. 1.2 Treatment of the first dose of good group to set good 100-200pg plus 0.9% saline 20ml slow static push, followed by 251μg / h speed vein to maintain. Pituitrin group to vasopressin by 0.2u / min speed intravenous infusion. Both groups were stopped bleeding (no vomiting, blood pressure and pulse normal and stable, stool transfer